Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers.

Saved in:
Bibliographic Details
Title: Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers.
Authors: Chawla SP; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A., Jeffrey S; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A., Pang SS; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A., Jones RL; Department of Medical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, U.K., VAN Gool SW; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany., Huber T; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany., Kosmal J; Department of Immunotherapy and Translational Medicine, IOZK Immun-Onkologisches Zentrum Köln, Cologne, Germany., Chawla NS; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A., Carter R; Department of Research and Development, BostonGene Corporation, Waltham, MA, U.S.A., Simone CB 2nd; Department of Radiation Oncology, New York Proton Center, New York, NY, U.S.A., Nael K; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, U.S.A., Bruckner H; Department of Medical Oncology, Bruckner Oncology, New York, NY, U.S.A., Gattani A; Department of Medical Oncology, Bruckner Oncology, New York, NY, U.S.A., Song PY; NKGen Biotech, Inc., Santa Ana, CA, U.S.A., Hall FL; Department of Research and Development, Aveni Foundation, Santa Monica, CA, U.S.A.; Department of Medical Oncology, Delta Next-Gene, LLC, Santa Monica, CA, U.S.A., Gordon EM; Department of Medical Oncology, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, U.S.A.; egordon@sarcomaoncology.com.; Department of Research and Development, Aveni Foundation, Santa Monica, CA, U.S.A.; Department of Medical Oncology, Delta Next-Gene, LLC, Santa Monica, CA, U.S.A.
Source: Anticancer research [Anticancer Res] 2026 Apr; Vol. 46 (4), pp. 2025-2034.
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1791-7530
DOI:10.21873/anticanres.18091